Invest ideasNews
22 Apr 2026, 17:50
GSR launches BESO ETF on Nasdaq tracking BTC, ETH, SOL
🚀 BESO ETF tracking BTC, ETH, and SOL just debuted on Nasdaq. Core3 ETF offers active management and dynamic weekly rebalancing. 🧑💼 Key point: Investors can access multi-crypto exposure in $BESO with a 1% management fee. Continue Reading: GSR launches BESO ETF on Nasdaq tracking BTC, ETH, SOL The post GSR launches BESO ETF on Nasdaq tracking BTC, ETH, SOL appeared first on COINTURK NEWS .
22 Apr 2026, 17:50
AI Drug Discovery Breakthrough: 10x Science Unlocks the Protein Characterization Bottleneck with $4.8M Funding
BitcoinWorld AI Drug Discovery Breakthrough: 10x Science Unlocks the Protein Characterization Bottleneck with $4.8M Funding In a significant move for the biotechnology sector, startup 10x Science has secured $4.8 million in seed funding to address a critical bottleneck in AI-driven drug discovery. Founded in December 2025, the company aims to transform how researchers characterize the flood of potential drug candidates generated by artificial intelligence models. This development, announced from San Francisco, CA, on April 30, highlights a pivotal shift from prediction to practical analysis in the race to develop new therapeutics. The AI Drug Discovery Bottleneck Artificial intelligence has revolutionized early-stage drug development, particularly through tools like Google DeepMind’s AlphaFold, which predicts protein structures with unprecedented accuracy. Consequently, AI models can now generate thousands of potential drug molecule candidates. However, a major impediment remains. Researchers must physically test and characterize each candidate to understand its real-world properties, a slow and resource-intensive process known as the characterization bottleneck. “You can add as many candidates as you want to the top of the funnel, but they all have to pass through this characterization process,” explained David Roberts, co-founder of 10x Science. “Everything needs to be measured.” This step is non-negotiable for regulatory approval and mass production, creating a significant logjam. For biologic drugs—complex medicines produced in living cells—understanding a protein’s precise structure is fundamental to ensuring it safely and effectively targets diseases like cancer. The Core Challenge: Mass Spectrometry Data The gold standard for molecular analysis is mass spectrometry. This technique measures molecules in an electric field to determine their atomic makeup. While powerful, it generates immensely complex datasets. Interpreting this data requires rare expertise and consumes vast amounts of a scientist’s time, slowing the entire drug development pipeline. The founders of 10x Science, Roberts, Andrew Reiter, and Vishnu Tejas, experienced this frustration firsthand while researching cancer immunology in a Stanford University lab. 10x Science’s AI-Powered Platform 10x Science’s solution is a proprietary software platform that merges deterministic algorithms from chemistry and biology with specialized AI agents. These agents are trained to interpret mass spectrometry data intelligently and traceably. A key innovation is the platform’s ability to make its analytical reasoning transparent, a crucial feature for regulatory compliance in the pharmaceutical industry. The platform’s practical impact is already being felt. Matthew Crawford, a scientist at Rilas Technologies, has used the software for several weeks. “I ran a particular protein through it, and it just kind of figured out, from what I named the file, what the protein probably was,” Crawford noted. The AI then autonomously searched online databases for the protein’s sequence, saving manual input time. Crawford praised the tool for making reasonable assumptions and providing clear explanations, attributing its effectiveness to the deep domain knowledge of its creators. Key capabilities of the 10x platform include: Autonomous data sourcing and sequence identification. Traceable analysis for audit and compliance trails. Adaptability to evaluate diverse molecule types. Funding, Traction, and Strategic Vision The $4.8 million seed round was led by Initialized Capital, with participation from Y Combinator, Civilization Ventures, and Founder Factor. The capital will fuel engineering hires and further model refinement. Significantly, 10x is already working with multiple major pharmaceutical companies and academic institutions, indicating strong early market validation. For investors, the company represents a unique proposition. “This is a SaaS platform that pharma has to pay for, every single month, to go through all of these potential candidates,” said Zoe Perret, a partner at Initialized. This model offers exposure to the biotech sector without the binary risk of a single drug’s clinical success. The founders’ specialized expertise in both biochemistry and AI presents a formidable barrier to entry for potential competitors. Beyond Characterization: A New Molecular Intelligence The company’s ambitions extend beyond streamlining a single process. Roberts envisions creating a new paradigm for understanding biology. “The deeper thing behind what we’re building is actually a new way to define molecular intelligence,” he stated. The long-term goal is to integrate protein structure data with other cellular information, providing a more holistic and dynamic view of biological systems to accelerate discovery. Conclusion The launch of 10x Science marks a critical evolution in AI drug discovery. By directly tackling the characterization bottleneck with a sophisticated, AI-powered platform, the startup is enabling researchers to validate AI-generated candidates faster and more reliably. This advancement not only accelerates the drug development timeline but also democratizes access to complex analytical techniques. As AI continues to generate a deluge of potential therapeutics, tools like those from 10x Science will be indispensable for translating digital promise into tangible, life-saving medicines. FAQs Q1: What is the main problem 10x Science is solving? 10x Science addresses the “characterization bottleneck” in AI drug discovery. While AI can rapidly generate thousands of potential drug candidates, physically testing and analyzing each one’s properties using techniques like mass spectrometry is slow, expensive, and requires rare expertise. Q2: How does the 10x Science platform work? The platform combines established scientific algorithms with AI agents specifically trained to interpret complex mass spectrometry data. It automates data analysis, provides traceable reasoning for compliance, and can autonomously source relevant information, significantly speeding up the characterization process. Q3: Who are the founders of 10x Science? The company was founded by David Roberts and Andrew Reiter, both experienced biochemists, and Vishnu Tejas, a serial founder with computer science and AI expertise. The trio previously collaborated in the Stanford lab of Nobel laureate Dr. Carolyn Bertozzi. Q4: Why is this important for the future of drug development? By making characterization faster and more accessible, 10x Science’s technology helps bridge the gap between AI-generated hypotheses and real-world testing. This can drastically shorten development timelines, reduce costs, and allow researchers to focus on the most promising candidates, potentially bringing new treatments to patients sooner. Q5: What is the business model for 10x Science? 10x Science operates on a Software-as-a-Service (SaaS) model. Pharmaceutical companies, biotech firms, and academic labs pay a recurring subscription fee to access the platform, providing a scalable revenue stream that is not dependent on the success of any single drug. This post AI Drug Discovery Breakthrough: 10x Science Unlocks the Protein Characterization Bottleneck with $4.8M Funding first appeared on BitcoinWorld .
22 Apr 2026, 17:49
‘Durable Market Bottom’ Has Occurred Around $60,000: Grayscale Research
Major crypto research firm and ETF issuer Grayscale has stated that the cryptocurrency has formed a “durable bottom” in recent months.
22 Apr 2026, 17:46
Ethereum ETFs Experience 9 Days of Inflows - A Signal for Price Surge?
22 Apr 2026, 17:45
Trump’s Fed Pick, Kevin Warsh, Warns of Tighter Liquidity: What It Means for Bitcoin
On Tuesday, Kevin Warsh, Donald Trump’s choice to replace Federal Reserve Chair Jerome Powell, testified before the Senate Banking Committee. He promised to be independent from the White House but did not promise to cut rates right away, leaving market watchers to try and figure out what a Warsh-led Fed would mean for liquidity and risk assets like Bitcoin (BTC). A Fed Shift From Rates to Balance Sheet The hearing had plenty of headline moments. Warsh told senators the Fed has “lost its way” and needs fundamental reform. He said under sworn testimony that Trump never asked him to commit to rate cuts at any specific meeting, a claim that clashed directly with Trump’s own statement to CNBC the same morning, where the president said he’d be “disappointed” if Warsh doesn’t cut immediately after taking office. Sen. Ruben Gallego did not let that slide : “Someone here is lying then; it’s either you or President Trump.” When Sen. John Kennedy asked if he’d be anyone’s “human sock puppet,” Warsh was blunt: “Absolutely not. I’ll be an independent actor if confirmed as chairman of the Federal Reserve.” On crypto, he was straightforward: “Crypto is now part of the US financial system,” and he ruled out a central bank digital currency on his watch. But the signal that actually matters for Bitcoin wasn’t about rates. Analysis published Tuesday by XWIN Research Japan argued that Warsh’s testimony pointed toward something more structural: balance sheet reduction. That’s quantitative tightening, which works by shrinking the Fed’s bond holdings and pulling liquidity out of the system. As XWIN put it, this targets not just the “price” of money via rates, but the “quantity” of liquidity itself. The uncomfortable scenario they describe is one where short-term rates fall while long-term yields rise, a combination that has historically been rough for risk assets. Warsh fed that interpretation directly. He told senators the Fed’s balance sheet is too large, should shrink, and that the central bank has no business holding long-term Treasuries. He also said he’d end the practice of Fed officials as publicly telegraphing rate moves in advance, arguing it locks policymakers into forecasts long after the data has changed. On-Chain Data Points the Other Way Bitcoin’s reaction during the hearing was quick. It dropped below $75,000 before recovering, and was trading around $78,000 at the time of writing, up about 2.7% over 24 hours and 5.4% on the week. What XWIN Research finds interesting, though, is what’s happening on-chain underneath all that noise. The Long-Term Holder SOPR, which tracks whether Bitcoin holders are selling at a profit or loss, is sitting around 1.0. That means they’re not aggressively cashing out. Historically, XWIN noted, it reflects reduced sell pressure and constrained supply. Put simply, despite the macro tightening, the available Bitcoin supply isn’t growing. Their read on the situation: macro liquidity is weakening while Bitcoin’s internal structure is holding up. That divergence, they argue, points to an accumulation phase rather than a clean breakdown, with the potential for a sharp move higher if ETF demand returns once liquidity conditions shift. The post Trump’s Fed Pick, Kevin Warsh, Warns of Tighter Liquidity: What It Means for Bitcoin appeared first on CryptoPotato .
22 Apr 2026, 17:45
Bitcoin Soars: BTC Price Surpasses $79,000 Milestone in Stunning Rally
BitcoinWorld Bitcoin Soars: BTC Price Surpasses $79,000 Milestone in Stunning Rally In a significant market development, the price of Bitcoin (BTC) has surged above the $79,000 threshold, marking a pivotal moment for the world’s leading cryptocurrency. According to real-time data from Bitcoin World market monitoring, BTC is currently trading at $79,000 on the Binance USDT trading pair. This price action represents a continuation of a powerful bullish trend that has captured global investor attention. Consequently, analysts are now scrutinizing the underlying factors propelling this ascent. Furthermore, this milestone invites a deeper examination of Bitcoin’s evolving role within the broader financial landscape. Bitcoin Price Breaks Through $79,000 Resistance The breakthrough past $79,000 is not an isolated event. It represents the culmination of sustained buying pressure over recent weeks. Market data shows consistent accumulation by both institutional and retail participants. For instance, on-chain metrics reveal a notable decrease in Bitcoin held on exchanges. This trend suggests a long-term holding mentality among investors. Additionally, trading volumes have spiked significantly across major platforms like Binance, Coinbase, and Kraken. The Binance USDT pair, specifically cited in the report, often acts as a key liquidity benchmark for the global market. Several technical indicators aligned to support this move. The price had consolidated below the previous all-time high for several days, building energy for an upward breakout. Key moving averages, such as the 50-day and 200-day, provided strong underlying support. Moreover, the Relative Strength Index (RSI), while elevated, had cooled from overbought territory, allowing room for this fresh advance. Market sentiment, as measured by tools like the Crypto Fear & Greed Index, has remained firmly in “Greed” territory, reflecting robust optimism. Institutional Catalysts and Macroeconomic Backdrop Beyond technicals, fundamental drivers are firmly in play. The approval and subsequent inflows into U.S. spot Bitcoin Exchange-Traded Funds (ETFs) have provided a structural tailwind. These financial products have funneled billions of dollars in new capital into the asset class. Simultaneously, macroeconomic conditions have fostered a favorable environment for scarce assets like Bitcoin. Persistent inflation concerns and a shifting interest rate outlook have led some investors to seek alternative stores of value. This confluence of factors creates a powerful narrative for Bitcoin’s price discovery. Analyzing the Current Cryptocurrency Rally Bitcoin’s rally often sets the tone for the entire digital asset market. This current cycle appears to follow that historical pattern, with Ethereum (ETH) and other major altcoins also posting substantial gains. However, Bitcoin’s dominance rate—its market share relative to the total crypto market—remains strong. This indicates that capital is flowing into the flagship asset first before rotating into higher-risk segments. The rally’s sustainability will depend on continued institutional adoption and regulatory clarity in major jurisdictions. The following table compares key Bitcoin metrics before and after crossing the $79,000 level: Metric Pre-Breakout Post-Breakout ($79k+) 24-Hour Trading Volume ~$45 Billion ~$68 Billion Exchange Reserve Declining Trend Accelerated Decline Network Hash Rate Near All-Time High Consistently High Active Addresses Elevated Spiking These data points collectively paint a picture of a healthy, organic advance. The rising hash rate signals strong network security and miner commitment. Meanwhile, the drop in exchange reserves underscores a preference for self-custody among holders. Expert Perspectives on Market Trajectory Financial analysts emphasize the importance of context. “Crossing $79,000 is psychologically important, but the underlying flows tell the real story,” notes a market strategist from a leading digital asset fund. “We are observing a fundamental shift where Bitcoin is being treated as a legitimate portfolio asset, not just a speculative tech bet.” Other experts point to the upcoming Bitcoin halving event, historically a catalyst for major bull markets, as a factor already being priced in by forward-looking investors. However, they uniformly caution that volatility remains an inherent feature of the asset class. Historical Context and Future Implications To understand the significance of the $79,000 level, one must look back. Bitcoin has experienced several boom-and-bust cycles, each reaching a new peak that dwarfed the last. This resilience has defined its decade-long history. The current price places Bitcoin’s total market capitalization well over $1.5 trillion, rivaling the size of some of the world’s largest corporations. This scale attracts different types of investors and increases systemic importance. The implications of this price achievement are multifaceted: Mainstream Validation: Higher prices garner media attention and public interest, driving further adoption. Regulatory Scrutiny: Success attracts more focused examination from policymakers worldwide. Technological Innovation: Value accrual funds continued development on the Bitcoin protocol and its Layer-2 solutions like the Lightning Network. Market Maturation: Increased liquidity and derivative product sophistication provide more tools for professional risk management. Moving forward, key levels to watch include potential resistance zones above $80,000 and the strength of any pullback support. The market will also closely monitor macroeconomic data, such as inflation reports and central bank statements, for cues that could affect risk assets broadly. Conclusion Bitcoin’s ascent above $79,000 marks a definitive chapter in its financial evolution. This milestone, observed on major exchanges like Binance, is supported by a combination of institutional investment, favorable macro conditions, and strong technical foundations. While the journey is characterized by inherent volatility, the current rally underscores Bitcoin’s growing integration into the global financial system. The Bitcoin price action serves as a critical barometer for digital asset sentiment and will continue to be a focal point for traders, investors, and economists alike as the market seeks to establish a new equilibrium. FAQs Q1: What does Bitcoin trading at $79,000 on Binance USDT mean? It means that on the Binance cryptocurrency exchange, one Bitcoin can be purchased or sold for 79,000 Tether (USDT) tokens, a stablecoin pegged to the US dollar. This pairing is a major global benchmark for BTC’s dollar-denominated price. Q2: What are the main reasons Bitcoin price is rising above $79,000? Primary drivers include sustained inflows into U.S. spot Bitcoin ETFs, macroeconomic uncertainty driving demand for scarce assets, positive market sentiment ahead of the next halving event, and increased institutional adoption as a treasury reserve asset. Q3: How does this price compare to Bitcoin’s all-time high? The $79,000 level represents a new all-time high for Bitcoin, surpassing its previous peak. Bitcoin’s price history is defined by cycles where it sets a new record high, experiences a correction, and eventually surpasses that record in a subsequent bull market. Q4: Is it too late to invest in Bitcoin after it crosses $79,000? Investment decisions depend on individual risk tolerance, financial goals, and time horizon. Cryptocurrencies are highly volatile. Many advocates promote a long-term, dollar-cost averaging strategy regardless of short-term price fluctuations, while others see elevated risk at new highs. Always conduct thorough research. Q5: What impact does a higher Bitcoin price have on the rest of the crypto market? Historically, a strong Bitcoin rally often leads to increased capital and positive sentiment flowing into the broader cryptocurrency market, a phenomenon known as “altcoin season.” However, Bitcoin’s dominance can also increase if it captures the majority of new investment inflows. This post Bitcoin Soars: BTC Price Surpasses $79,000 Milestone in Stunning Rally first appeared on BitcoinWorld .
